← All trials
NCT03158389
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2017
- Primary completion
- Sep 30, 2023
- Completion date
- Sep 30, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 350
- Arms / groups
- 7 / —
- Source
- AACT · pre-existing
Sponsors
- University of HeidelbergLead sponsor
- German Cancer Research CenterCollaborator
- University of HeidelbergCollaborator
- Deutsche Krebshilfe e.V.Collaborator
- University of HeidelbergOverall official - principal investigator
- University of HeidelbergReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.